[ORGANIZATION]
GLP‑1 receptor agonist drugs
Featured in 1 tracked story · first seen
Situations
GLP‑1 weight‑loss drug efficacy
2 clusters · 2 sources · last updated
Latest: GLP‑1 weight‑loss injections mainly burn fat, not muscle, in first three months
In late June 2026 an oral GLP‑1 compound, Aleniglipron, reported up to a 12 % reduction in body weight during a phase‑2b trial, indicating strong promise for a non‑injectable obesity treatment. A month later a meta‑anal